NYSE:VAR - Varian Medical Systems Stock Price, Price Target & More

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Varian Medical Systems, Inc. (NYSE:VAR) announced its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.04 by $0.11. The medical equipment provider had revenue of $729.90 million for the quarter, compared to analyst estimates of $685.86 million. Varian Medical Systems had a return on equity of 27.99% and a net margin of 4.77%. The business's revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.89 EPS. View Varian Medical Systems' Earnings History.

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Varian Medical Systems.

Varian Medical Systems issued an update on its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $4.43-4.53 for the period, compared to the Thomson Reuters consensus estimate of $4.40. The company issued revenue guidance of +6-9% (Approx $3.11-3.21 billion), compared to the consensus revenue estimate of $2.79 billion.

8 analysts have issued twelve-month price targets for Varian Medical Systems' shares. Their forecasts range from $98.00 to $132.00. On average, they anticipate Varian Medical Systems' share price to reach $111.2857 in the next twelve months. This suggests that the stock has a possible downside of 4.2%. View Analyst Ratings for Varian Medical Systems.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 3 sell ratings, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Varian Medical Systems include SONOVA Hldg AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), AxoGen, Inc Common Stock (AXGN), NxStage Medical (NXTM), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), BioLife Solutions (BLFS), Vision Sciences (CGNT), Rockwell Medical (RMTI), Helius Medical Technologies (HSDT) and Fonar (FONR).

News articles about VAR stock have trended somewhat positive on Friday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Varian Medical Systems earned a news impact score of 0.21 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 47.13 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Varian Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Alecta Pensionsforsakring Omsesidigt (1.74%), Oakbrook Investments LLC (0.36%), Saratoga Research & Investment Management (0.30%), Hardman Johnston Global Advisors LLC (0.23%), Bank of Montreal Can (0.11%) and Montrusco Bolton Investments Inc. (0.10%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, David J Illingworth, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

VAR stock was sold by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Saratoga Research & Investment Management, State of Alaska Department of Revenue, Hardman Johnston Global Advisors LLC, Hartford Investment Management Co., Meag Munich Ergo Kapitalanlagegesellschaft MBH and TNB Financial. Company insiders that have sold Varian Medical Systems company stock in the last year include David J Illingworth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

VAR stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, DnB Asset Management AS, Nisa Investment Advisors LLC, Calamos Advisors LLC, Montrusco Bolton Investments Inc., Clinton Group Inc., Cohen Klingenstein LLC and Welch & Forbes LLC. View Insider Buying and Selling for Varian Medical Systems.

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of VAR stock can currently be purchased for approximately $116.20.

Varian Medical Systems has a market capitalization of $10.62 billion and generates $2.67 billion in revenue each year. The medical equipment provider earns $249.60 million in net income (profit) each year or $3.60 on an earnings per share basis. Varian Medical Systems employs 6,600 workers across the globe.

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]